+ Follow PHARMACOECONOMICS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 399631
[Title] => The benefits of omega-3 fish oil
[Summary] => Patients with heart diseases always face the threat of sudden death or a potentially life-threatening irregularity of the heartbeat called arrhythmia.
[DatePublished] => 2008-09-11 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 240418
[Title] => Empowering patients in treatment of chronic diseases
[Summary] => Weakened they may be because of their chronic illnesses, patients are now getting to be empowered to actively take part in their own treatment.
Traditionally, patients let their doctors decide what drug to take and the length of treatment. The fast-changing times have also brought changes in the way chronic diseases are managed. Far from being a passive observer, patients are now playing a more active role in the management of their chronic illnesses.
[DatePublished] => 2004-02-26 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 237723
[Title] => Making affordable healthcare happen
[Summary] => Affordable healthcare has become a thing of the past. Medical services are now a major family expense, costing hundreds and thousands of pesos each month.
Many find even basic healthcare costs and routine prescription medicines out of financial reach. A growing number of families must choose between groceries or medicines, and many decide to take the gamble, choosing the former over the latter. They would rather forego the medication than let the family go hungry.
[DatePublished] => 2004-02-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 232079
[Title] => Treatment non-compliance can be risky for patients
[Summary] => Patients may not realize that they’re exposing themselves to a high risk of the complications of their disease if they are not compliant in taking their medications. Non-compliance is also more expensive in the long run if the disease becomes more complicated because of poor control.
[DatePublished] => 2003-12-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 230329
[Title] => Therapharma rolls back price of statin
[Summary] => Patients taking the cholesterol-lowering statins are in for a Christmas treat as Therapharma announces an 18 to 22 percent price rollback of its brand of simvastatin.
The drug comes in 10, 20 and 40-mg stock doses.
James Dio, Therapharma general manager, said they have converted into an actual price rollback the discounts which the company has been giving patients through its Health Plus Value Program.
"Now, everyone can benefit from this general price reduction," Dio said.
[DatePublished] => 2003-12-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 227767
[Title] => Making affordable healthcare happen
[Summary] => Affordable healthcare has become a thing of the past. Medical services are now a major family expense, costing hundreds and thousands of pesos each month. Many find even basic healthcare costs and routine prescription medicines out of financial reach.
A growing number of families must choose between groceries or medicines, and many decide to take the gamble, choosing the former over the latter. They would rather forego the medication than let the family go hungry.
[DatePublished] => 2003-11-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 226068
[Title] => A solution to treatment non-compliance
[Summary] => Gerardo D. came home depressed by what his doctor told him. He was diagnosed to have pulmonary tuberculosis or PTB a year ago. He took his medicines erratically and even discontinued it after a few months when he felt better against his doctor’s advice.
He did not report back to his physician until he started losing weight again with cough and fever, especially at night. After doing x-rays and sputum examinations, his doctor said that his PTB has not only recurred, but has gotten worse. And there is a chance that he may be resistant to usual anti-TB therapy.
[DatePublished] => 2003-10-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 224395
[Title] => Patient non-compliance: Dangerous and costly
[Summary] => Yoly R., a 58-year-old housewife, has been treated for diabetes for more than 10 years. She took her medicines erratically, resulting in poor blood sugar control. Recently, her left leg had to be amputated because of gangrene.
[DatePublished] => 2003-10-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 221973
[Title] => Price competition benefits patients
[Summary] => And the battle begins. Much like the way cholesterol stiffens the arteries causing heart problems, competition in the local anticholesterol market also stiffens, but in a favorable way for the patients, with multinationals rolling back their prices by as much as 57 percent.
This decision, according to some medical practitioners, is a welcome development in the pharmaceutical industry, which was likely triggered by the introduction of a bioequivalent brand of simvastatin by a local company which was sold at half the price of the innovator product.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 220872
[Title] => An alternative to increasing healthcare costs
[Summary] => In an era of increasing health care costs, physicians and patients alike are finding ways by which the financial burden of being sick will be lessened.
In the United States and even in the Philippines, the concept of generic prescription is being recommended to give the patient therapeutic options with the aim of reducing the cost of prescribed drugs.
One brand may be substituted for another brand by the prescribing physician provided the alternative brand has been shown to be bioequivalent in potency to the standard drug.
[DatePublished] => 2003-09-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PHARMACOECONOMICS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 399631
[Title] => The benefits of omega-3 fish oil
[Summary] => Patients with heart diseases always face the threat of sudden death or a potentially life-threatening irregularity of the heartbeat called arrhythmia.
[DatePublished] => 2008-09-11 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 240418
[Title] => Empowering patients in treatment of chronic diseases
[Summary] => Weakened they may be because of their chronic illnesses, patients are now getting to be empowered to actively take part in their own treatment.
Traditionally, patients let their doctors decide what drug to take and the length of treatment. The fast-changing times have also brought changes in the way chronic diseases are managed. Far from being a passive observer, patients are now playing a more active role in the management of their chronic illnesses.
[DatePublished] => 2004-02-26 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 237723
[Title] => Making affordable healthcare happen
[Summary] => Affordable healthcare has become a thing of the past. Medical services are now a major family expense, costing hundreds and thousands of pesos each month.
Many find even basic healthcare costs and routine prescription medicines out of financial reach. A growing number of families must choose between groceries or medicines, and many decide to take the gamble, choosing the former over the latter. They would rather forego the medication than let the family go hungry.
[DatePublished] => 2004-02-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 232079
[Title] => Treatment non-compliance can be risky for patients
[Summary] => Patients may not realize that they’re exposing themselves to a high risk of the complications of their disease if they are not compliant in taking their medications. Non-compliance is also more expensive in the long run if the disease becomes more complicated because of poor control.
[DatePublished] => 2003-12-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 230329
[Title] => Therapharma rolls back price of statin
[Summary] => Patients taking the cholesterol-lowering statins are in for a Christmas treat as Therapharma announces an 18 to 22 percent price rollback of its brand of simvastatin.
The drug comes in 10, 20 and 40-mg stock doses.
James Dio, Therapharma general manager, said they have converted into an actual price rollback the discounts which the company has been giving patients through its Health Plus Value Program.
"Now, everyone can benefit from this general price reduction," Dio said.
[DatePublished] => 2003-12-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 227767
[Title] => Making affordable healthcare happen
[Summary] => Affordable healthcare has become a thing of the past. Medical services are now a major family expense, costing hundreds and thousands of pesos each month. Many find even basic healthcare costs and routine prescription medicines out of financial reach.
A growing number of families must choose between groceries or medicines, and many decide to take the gamble, choosing the former over the latter. They would rather forego the medication than let the family go hungry.
[DatePublished] => 2003-11-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 226068
[Title] => A solution to treatment non-compliance
[Summary] => Gerardo D. came home depressed by what his doctor told him. He was diagnosed to have pulmonary tuberculosis or PTB a year ago. He took his medicines erratically and even discontinued it after a few months when he felt better against his doctor’s advice.
He did not report back to his physician until he started losing weight again with cough and fever, especially at night. After doing x-rays and sputum examinations, his doctor said that his PTB has not only recurred, but has gotten worse. And there is a chance that he may be resistant to usual anti-TB therapy.
[DatePublished] => 2003-10-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 224395
[Title] => Patient non-compliance: Dangerous and costly
[Summary] => Yoly R., a 58-year-old housewife, has been treated for diabetes for more than 10 years. She took her medicines erratically, resulting in poor blood sugar control. Recently, her left leg had to be amputated because of gangrene.
[DatePublished] => 2003-10-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 221973
[Title] => Price competition benefits patients
[Summary] => And the battle begins. Much like the way cholesterol stiffens the arteries causing heart problems, competition in the local anticholesterol market also stiffens, but in a favorable way for the patients, with multinationals rolling back their prices by as much as 57 percent.
This decision, according to some medical practitioners, is a welcome development in the pharmaceutical industry, which was likely triggered by the introduction of a bioequivalent brand of simvastatin by a local company which was sold at half the price of the innovator product.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 220872
[Title] => An alternative to increasing healthcare costs
[Summary] => In an era of increasing health care costs, physicians and patients alike are finding ways by which the financial burden of being sick will be lessened.
In the United States and even in the Philippines, the concept of generic prescription is being recommended to give the patient therapeutic options with the aim of reducing the cost of prescribed drugs.
One brand may be substituted for another brand by the prescribing physician provided the alternative brand has been shown to be bioequivalent in potency to the standard drug.
[DatePublished] => 2003-09-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
September 11, 2008 - 12:00am
February 26, 2004 - 12:00am
February 5, 2004 - 12:00am
December 18, 2003 - 12:00am
December 4, 2003 - 12:00am
November 13, 2003 - 12:00am
October 30, 2003 - 12:00am
October 16, 2003 - 12:00am
September 25, 2003 - 12:00am
September 18, 2003 - 12:00am
